BioSpace News Archive

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report financial results for the three months ended March 31, 2021 after the close of the U.S. financial markets on Monday, May 3, 2021 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Speakers on the call will include Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg.

National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2021

Urges Stockholders to Vote the WHITE Proxy Card “FOR” ALL of Adverum’s Three Highly Qualified, Diverse and Independent Directors: Dawn Svoronos, Reed V. Tuckson, M.D. and Thomas Woiwode, Ph.D.

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, May 6, 2021, following the release of its first quarter 2021 financial results.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the “Company” or “Jazz”) today announced the pricing of the previously announced offering (the “Offering”) of $1.5 billion in an aggregate principal amount of 4.375% senior secured notes due 2029 (the “Notes”) by Jazz

The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.39 per share.

Veritas today announced EduSafe, the streamlined, user-friendly COVID-19 testing solution that K-12 schools, early education centers, and summer camps need. Utilizing a proven in-lab pooled PCR protocol vetted by educators, early childhood specialists,

The data abstracts to be presented at AAD VMX reinforce that ILUMYA is a long-lasting biologic treatment choice for patients with moderate-to-severe plaque psoriasis through five years of continuous treatment.

Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced the publication of preclinical research demonstrating clinical benefit of its chaperone-mediated autophagy activator platform in mice models of Alzheimer’s disease.

We are pleased to announce that MediPines AGM100™, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards.